Phi Med Europe
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Phi Med Europe is a medical technology company that develops and manufactures diagnostic devices for the early detection and monitoring of sensory neurological dysfunctions, particularly diabetic neuropathy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phi Med Europe Comparables
Compare Phi Med Europe with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Somedic SenseLab AB | 85% | |
| Yostra Labs | 84% | |
| Ayati Devices | 82% | |
Phi Med Europe Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 48% MoM.
Phi Med Europe Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Phi Med Europe's valuation, stock price, and market status.